WARNING: As this organisation lists one or more EP accredited lobbyists, it is highly improbable that its lobbying costs are lower than €10,000.
WARNING: The lobbying costs declared by this organisation are extraordinarily high and may therefore have been over-declared.
600,000€ - 699,999€
Lobbyists declared: 11 FTE (14)
WARNING: The number of full time equivalent lobbyists declared by this organisation are extraordinarily high and may therefore have been over-declared.
Lobbyists with EP accreditation: 5
Meetings with European Commission: 9
Lobbying costs over the years:
Registration on EU Transparency Register
Goals / Remit
PA Europe N.V./S.A. provides political advice and operational support to Governments, industries and NGOs in several parts of Europe through its offices in Brussels and The Hague.
PA Europe N.V./S.A. has sister organisations in Asia (PA Asia - Beijing, Hong Kong, Jakarta) and the Middle East (Muscat).
PA Europe and the PA International Foundation focus at 3 securities: water security, food security/food safety, and job security. Most if not all PA dossiers coincide with these focal points. Through the PA International Foundation advice and services are provided free of charge. Through PA Europe services are provided through contractual agreements. In the past 5 years Antimicrobial Resistance, air pollution, cancerous chemicals, (child) malnutrition and neglected diseases have been among both Foundation and company activities. In terms of regulatory work the focus of PA Europe is at: - Regulation (EC) 1107/2009 concerning the placing of plant protection products on the market of DG SANTE; Directive 2009/128/EC of the European Parliament and of the Council of 21 October 2009 establishing a framework for Community action to achieve the sustainable use of pesticides of DG SANTE [faster access to market for low-risk (bio-) plant protection products] - Antimicrobial Resistance incl. Animal Health Law, Feed Additives Legislation 1831/2003 [sharp reduction of production and distribution of antibiotics in animal husbandry and in human health, including the replacement of antibiotics in husbandry by non-antibiotic alternatives; final deliverable: antibiotics in husbandry only for therapeutic purposes; vigilance throughout public health institutions with regards to antibiotics use] - IMI, IMI 2, Horizon 2020, MFF post 2020 [promotion of medicinal research and development within the EU] and other funding mechanisms for medical research and development - EMIS Committee recommendations [support for damaged groups as a consequence of illegal mechanisms in breach of environmental/emission laws and regulations] - Collective redress in case of Foreign Exchange market manipulation - Reg. (EC) No 853/20041: food safety/listeria contamination - The European Commission’s 315 billion euro Investment Plan and the proposed Regulation 2015/0009 establishing the European Fund for Strategic Investments; The European Investment Bank’s External Lending Mandate 2014-2020 [creating a European competitive alternative for long-term/low-conditionalities lending by Asian banks and institutions] - Plastics overuse and waste - Regulation (EC) No 1907/2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) - Avoid regulatory consequences causing strengthened attractiveness of cigarette smoking - Innovative technologies for gene-editing - EU policies on Terrorism - EU-China Trade - EU-Indonesia Trade - EU-Japan trade - EU-ASEAN trade - EU-GCC trade
Tel: 32 27358396
Lobbyists with EP accreditation
Person in charge of EU relations
Person with legal responsibility
Belgian-Chinese Chamber of Commerce (BCECC)
Netherlands Atlantic Association
Netherlands Society for International Affairs (NGIZ)
International Institute for Strategic Studies (IISS)
Procurement from EU institutions
Grants from EU institutions
Total public financing
Other financial information
Clients generating a turnover of 300000-399999 €
Clients generating a turnover of 100000-199999 €
International Biocontrol Manufacturers Association
Clients generating a turnover of 50000-99999 €
There are no notes attached to this organisation.
Expert groups (European Commission)
Intergroups (European Parliament)
Industry forums (European Parliament)
PA Europe helps develop and manage strategic and corporate communications of various clients (Governments, companies, NGOs, industry associations, societal organisations) from different fields (food, energy, environment, biotech, telecoms, etc.) vis-à-vis third party stakeholders – which provides PA with a very broad view of EU policies. This amongst others includes: - Political and regulatory research and advice - Government relations, including EU institutions - Development of a communication strategy and framework - Pro-active and selective media approaches - Silent diplomacy and lobbying/political communication - Dialogue and engagement with societal stakeholders - Crisis management and crisis communication as well as traditional PR strategizing
Meetings with European Commission9 meetings found.
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't publish information about such meetings. All information below comes from European Commission web pages.
- 12 Dec 2019 - Director-General Anne Bucher - Legislative and non-legislative options for combating AMR and promoting PPP biocontrol tools (DG Health and Food Safety)
- 13 Mar 2019 - Robert Schröder - Health R&I (DG Research)
- 05 Nov 2018 - Robert Schröder - Health initiatives under FP9 (DG Research)
- 20 May 2015 - Edward Bannerman - International aspects of investment plan (DG Jobs & Growth)
- 14 Jan 2015 - Commissioner Vytenis Andriukaitis - Antimicrobial resistance (DG Health)
- 14 Jan 2015 - Arunas Vinciunas - Antimicrobial resistance (DG Health)
- 13 Jan 2015 - Rolf Carsten Bermig - Juncker Investment plan, in particular the possibilitiy to extend the scope to investments outside the EU (DG Internal Market)
- 13 Jan 2015 - Rolf Carsten Bermig - Introductory meeting (DG Internal Market)
- 09 Jan 2015 - Martin Selmayr - Outside EU-investments (DG Presidency)